Ole Maaløes Vej 3, DK-2200 Copenhagen N Denmark | VIA EDGAR |
September 25, 2020
U.S. Securities and Exchange Commission
Office of Life Sciences
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 4546
Washington, D.C. 20549
| Attn: | Mr. Alan Campbell |
Ms. Christine Westbrook
Mr. David Burton
Ms. Mary Mast
| Re: | Orphazyme A/S |
Registration Statement on Form F-1, as amended
File No. 333-248607
Acceleration Request
Requested Date: Monday, September 28, 2020
Requested Time: 4:00 P.M. Eastern Daylight Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-1 (File No. 333-248607) (the “Registration Statement”) to become effective on September 28, 2020, at 4:00 p.m., Eastern Daylight Time, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff (the “Staff”). The Registrant hereby withdraws its original request for acceleration, dated September 22, 2020, pursuant to which acceleration had previously been requested to 4:00 p.m., Eastern Daylight Time, on September 24, 2020, or as soon as practicable thereafter.
Once the Registration Statement has been declared effective, please orally confirm that event with Josh Kaufman of Cooley LLP (212) 479-6495, counsel to the Registrant, Alison Haggerty at (212) 479-6596 or Divakar Gupta at (212) 479-6474.
Very truly yours,
Orphazyme A/S
By: /s/ Kim Stratton
Kim Stratton
Chief Executive Officer
| cc: | Anders Vadsholt, Orphazyme A/S |
Alison Haggerty, Cooley LLP
Divakar Gupta, Cooley LLP
Mark Ballantyne, Cooley LLP
Ilir Mujalovic, Shearman & Sterling LLP
[Signature Page to Acceleration Request]